Butylated Hydroxytoluene vs Recombinant Bovine Somatotropin: which is worse?
Quick answer: Recombinant Bovine Somatotropin carries the heavier risk profile. Butylated Hydroxytoluene is — in the EU and — in the US; Recombinant Bovine Somatotropin is — in the EU and — in the US.
| Property | Butylated Hydroxytoluene | Recombinant Bovine Somatotropin |
|---|---|---|
| EU status | — | — |
| US status | — | — |
| Risk level | — | — |
| Banned in | Japan (banned for food use) | European Union, Canada, Japan, Australia, New Zealand |
| Restricted in | European Union (ADI-based restrictions), United Kingdom, Australia | — |
| Category | additive | additive |
| Where it hides | — | — |
What is Butylated Hydroxytoluene?
Butylated hydroxytoluene (BHT) is a synthetic phenolic antioxidant preservative derived from petroleum. A white crystalline solid with formula C15H24O, it prevents fat oxidation in processed foods, cosmetics, and industrial applications. Often used synergistically with BHA.
What is Recombinant Bovine Somatotropin?
Recombinant bovine somatotropin (rBST) is the synthetic version of bovine growth hormone (BST), naturally produced by the pituitary gland in cattle. The recombinant version is produced using genetically engineered bacteria and is injected into dairy cows to increase milk production by 10-15%. Brand name: Posilac.
Documented risks
Butylated Hydroxytoluene: BHT has complex, bidirectional carcinogenicity data — some NTP bioassays found liver tumors in female mice at high doses, while other studies suggested BHT might inhibit cancer initiation. IARC has not formally classified BHT due to conflicting evidence. A 2017 study linked BHT to thyroid hormone disruption in female rats. The American Academy of Pediatrics (2018) recommended reducing synthetic preservative exposure including BHT in children. Kellogg's uses vitamin E in European versions of cereals that contain BHT in US versions — a commercially meaningful substitution.
Recombinant Bovine Somatotropin: See recombinant-bovine-growth-hormone-rbgh for full detail. Key concerns: rBST elevates IGF-1 in milk; elevated blood IGF-1 is associated with breast, prostate, and colorectal cancer risk in epidemiological studies. Animal welfare: increased mastitis (up to 25-50% higher rates), lameness, and antibiotic use. The Codex Alimentarius Commission declined to endorse rBST safety MRLs in a historic 33-29 vote. Health Canada rejected rBST approval in 1999 after finding it caused significant animal health problems requiring increased antibiotic use.
Scan a barcode and we'll flag both Butylated Hydroxytoluene and Recombinant Bovine Somatotropin (plus 200+ other ingredients banned overseas).
Scan free →